Health & Environmental Research Online (HERO)


Print Feedback Export to File
6322106 
Journal Article 
Palbociclib Plus Fulvestrant as First-Line Therapy for Patients with Locally Advanced, Inoperable or Metastatic HR+/HER2-Breast Cancer in Germany: Interim Results of the Inge-B Phase 2 Study 
Welt, A; Welslau, M; Lueftner, D; Deryal, M; Liersch, R; Sahlmann, J; Houet, L; Potthoff, K; Marschner, N; Vannier, C 
2020 
ONCOLOGY RESEARCH AND TREATMENT
ISSN: 2296-5270 
43 
13-14